|
Jun 4
|
BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
|
|
Jun 4
|
Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?
|
|
Jun 3
|
The Best Stocks to Invest $1,000 in Right Now
|
|
Jun 2
|
The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip
|
|
May 29
|
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
|
|
May 21
|
Crispr Therapeutics call volume above normal and directionally bullish
|
|
May 21
|
3 Top Genomics Stocks to Add to Your Portfolio in 2025
|
|
May 21
|
CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug
|
|
May 20
|
CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA Therapies
|
|
May 20
|
5 Monster Stocks to Hold for the Next 10 Years
|
|
May 20
|
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
|
|
May 19
|
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
|
|
May 18
|
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
|
|
May 14
|
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
|
|
May 13
|
2 Biotech Stocks That Are Screaming Buys in May
|
|
May 12
|
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
|
|
May 10
|
3 Monster Stocks to Hold for the Next 10 Years
|
|
May 8
|
CRISPR Therapeutics (NasdaqGM:CRSP) Q1 2025 Revenue Increases 71% to US$1 Million
|
|
May 8
|
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
|
|
May 8
|
CRISPR Therapeutics First Quarter 2025 Earnings: Misses Expectations
|